140 related articles for article (PubMed ID: 17213805)
1. TLX1/HOX11-induced hematopoietic differentiation blockade.
Riz I; Akimov SS; Eaker SS; Baxter KK; Lee HJ; Mariño-Ramírez L; Landsman D; Hawley TS; Hawley RG
Oncogene; 2007 Jun; 26(28):4115-23. PubMed ID: 17213805
[TBL] [Abstract][Full Text] [Related]
2. TLX1/HOX11 transcription factor inhibits differentiation and promotes a non-haemopoietic phenotype in murine bone marrow cells.
Dixon DN; Izon DJ; Dagger S; Callow MJ; Taplin RH; Kees UR; Greene WK
Br J Haematol; 2007 Jul; 138(1):54-67. PubMed ID: 17555447
[TBL] [Abstract][Full Text] [Related]
3. TLX1/HOX11-mediated disruption of primary thymocyte differentiation prior to the CD4+CD8+ double-positive stage.
Owens BM; Hawley TS; Spain LM; Kerkel KA; Hawley RG
Br J Haematol; 2006 Jan; 132(2):216-29. PubMed ID: 16398656
[TBL] [Abstract][Full Text] [Related]
4. Hematopoietic immortalizing function of the NKL-subclass homeobox gene TLX1.
Zweier-Renn LA; Hawley TS; Burkett S; Ramezani A; Riz I; Adler RL; Hickstein DD; Hawley RG
Genes Chromosomes Cancer; 2010 Feb; 49(2):119-31. PubMed ID: 19862821
[TBL] [Abstract][Full Text] [Related]
5. TLX1 and NOTCH coregulate transcription in T cell acute lymphoblastic leukemia cells.
Riz I; Hawley TS; Luu TV; Lee NH; Hawley RG
Mol Cancer; 2010 Jul; 9():181. PubMed ID: 20618946
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of stem cell associated ALDH1A1, a target of the leukemogenic transcription factor TLX1/HOX11, inhibits lymphopoiesis and promotes myelopoiesis in murine hematopoietic progenitors.
Rice KL; Izon DJ; Ford J; Boodhoo A; Kees UR; Greene WK
Leuk Res; 2008 Jun; 32(6):873-83. PubMed ID: 18082256
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional regulation of FHL1 by TLX1/HOX11 is dosage, cell-type and promoter context-dependent.
Rice KL; Kees UR; Greene WK
Biochem Biophys Res Commun; 2008 Mar; 367(3):707-13. PubMed ID: 18073142
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional activation by TLX1/HOX11 involves Gro/TLE corepressors.
Riz I; Lee HJ; Baxter KK; Behnam R; Hawley TS; Hawley RG
Biochem Biophys Res Commun; 2009 Mar; 380(2):361-5. PubMed ID: 19250647
[TBL] [Abstract][Full Text] [Related]
9. Transient responses to NOTCH and TLX1/HOX11 inhibition in T-cell acute lymphoblastic leukemia/lymphoma.
Rakowski LA; Lehotzky EA; Chiang MY
PLoS One; 2011 Feb; 6(2):e16761. PubMed ID: 21326611
[TBL] [Abstract][Full Text] [Related]
10. The nuclear oncoprotein TLX1/HOX11 associates with pericentromeric satellite 2 DNA in leukemic T-cells.
Heidari M; Rice KL; Phillips JK; Kees UR; Greene WK
Leukemia; 2006 Feb; 20(2):304-12. PubMed ID: 16357834
[TBL] [Abstract][Full Text] [Related]
11. TLX1-induced T-cell acute lymphoblastic leukemia.
De Keersmaecker K; Ferrando AA
Clin Cancer Res; 2011 Oct; 17(20):6381-6. PubMed ID: 21705452
[TBL] [Abstract][Full Text] [Related]
12. Loss of Ubr1 promotes aneuploidy and accelerates B-cell lymphomagenesis in TLX1/HOX11-transgenic mice.
Chen E; Kwon YT; Lim MS; Dubé ID; Hough MR
Oncogene; 2006 Sep; 25(42):5752-63. PubMed ID: 16862188
[TBL] [Abstract][Full Text] [Related]
13. G1/S transcriptional networks modulated by the HOX11/TLX1 oncogene of T-cell acute lymphoblastic leukemia.
Riz I; Hawley RG
Oncogene; 2005 Aug; 24(36):5561-75. PubMed ID: 15897879
[TBL] [Abstract][Full Text] [Related]
14. The DN2 Myeloid-T (DN2mt) Progenitor is a Target Cell for Leukemic Transformation by the TLX1 Oncogene.
Zweier-Renn LA; Riz I; Hawley TS; Hawley RG
J Bone Marrow Res; 2013 Feb; 1():. PubMed ID: 25309961
[TBL] [Abstract][Full Text] [Related]
15. Cooperative Enhancer Activation by TLX1 and STAT5 Drives Development of NUP214-ABL1/TLX1-Positive T Cell Acute Lymphoblastic Leukemia.
Vanden Bempt M; Demeyer S; Broux M; De Bie J; Bornschein S; Mentens N; Vandepoel R; Geerdens E; Radaelli E; Bornhauser BC; Kulozik AE; Meijerink JP; Bourquin JP; de Bock CE; Cools J
Cancer Cell; 2018 Aug; 34(2):271-285.e7. PubMed ID: 30107177
[TBL] [Abstract][Full Text] [Related]
16. A promoter with bidirectional activity is located between TLX1/HOX11 and a divergently transcribed novel human gene.
Greene WK; Sontani Y; Sharp MA; Dunn DS; Kees UR; Bellgard MI
Gene; 2007 Apr; 391(1-2):223-32. PubMed ID: 17303350
[TBL] [Abstract][Full Text] [Related]
17. Erythroid inhibition by the leukemic fusion AML1-ETO is associated with impaired acetylation of the major erythroid transcription factor GATA-1.
Choi Y; Elagib KE; Delehanty LL; Goldfarb AN
Cancer Res; 2006 Mar; 66(6):2990-6. PubMed ID: 16540647
[TBL] [Abstract][Full Text] [Related]
18. The promise of Hox11+ stem cells of the spleen for treating autoimmune diseases.
Lonyai A; Kodama S; Burger D; Davis M; Faustman DL
Horm Metab Res; 2008 Feb; 40(2):137-46. PubMed ID: 18283632
[TBL] [Abstract][Full Text] [Related]
19. MEIS proteins as partners of the TLX1/HOX11 oncoprotein.
Milech N; Gottardo NG; Ford J; D'Souza D; Greene WK; Kees UR; Watt PM
Leuk Res; 2010 Mar; 34(3):358-63. PubMed ID: 19559479
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the genome-wide TLX1 binding profile in T-cell acute lymphoblastic leukemia.
Durinck K; Van Loocke W; Van der Meulen J; Van de Walle I; Ongenaert M; Rondou P; Wallaert A; de Bock CE; Van Roy N; Poppe B; Cools J; Soulier J; Taghon T; Speleman F; Van Vlierberghe P
Leukemia; 2015 Dec; 29(12):2317-27. PubMed ID: 26108691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
